Hovid Berhad operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hovid Berhad with three other
pharmaceutical manufacturers in Asia:
Mangalam Drugs & Organics Limited
sales of 2.95 billion Indian Rupees [US$44.22 million]
(3.04 billion Indian Rupees [US$45.62 million]
Caplin Point Laboratories Limited
based in India
(3.08 billion Indian Rupees [US$46.24 million]
of which 100%
Hovid Berhad reported sales of 189.03 million Malaysian Ringgits (US$44.93 million)
June of 2016.
a very small
increase of 0.3%
versus 2015, when the company's sales were 188.41 million Malaysian Ringgits.
Sales at Hovid Berhad have increased during each of the previous five years
(and since 2011, sales have increased a total of 23%).